Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study

By D. Juurlink, M. Mamdani, Douglas S. Lee, A. Kopp, Peter C. Austin, A. Laupacis, Donald A. Redelmeier. 2004

958 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/e3974350f2bebe52882f9a12be6039b226381861

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Victor P Pontes
2. H. Weisberg
3. Susan Athey

Citations in the corpus

• Post hoc subgroups in clinical trials: Anathema or analytics? (2015, methodology): “Unfortunately, in a routine care setting, a high incidence of hyperkalemia became evident, discouraging physicians from using spironolactone for heart-failure treatment.(14) We conducted a reanalysis of the RALES data using the cadit approach described above.”